The laboratory
The Santa Fe Laboratory exists to evaluate dysautonomias and movement disorders with reproducible protocols, in children, adolescents, and adults in Mexico and Latin America, without lowering the international standard. The family is part of the process.
Clinical direction
Neurologist · Clinical director
Director of the Autonomic and Movement Disorders Clinical Research Laboratory Santa Fe, and a neurohospitalist in Mexico City.
M.D., Universidad Autónoma del Estado de México. Residencies in Internal Medicine and Neurology at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Clinical fellowship in neurodegenerative disease and movement disorders at the Instituto Nacional de Neurología y Neurocirugía.
Post-doctoral research fellowship at the Dysautonomia Center, NYU Grossman School of Medicine, and an MDS-PAS visiting traineeship at the University of Cincinnati Movement Disorders Clinic.
His clinical and research work focuses on neurogenic orthostatic hypotension, pure autonomic failure, synucleinopathy phenoconversion, and the standardization of autonomic testing for Latin American settings.
Toluca: 2615052002A00378, a new notice. The previous one became obsolete when the diagnostic cabinet and the advertised study catalog were added. It covers the diagnostic services advertised for Toluca. Santa Fe: 2609072002A00073. Pachuca: 2613012002A00217. Each permit covers only its own site.
Toluca: 2615055036B00246. The notice was amended to add a specialized diagnostic-cabinet activity, SCIAN 621511 (medical and diagnostic laboratories), in addition to consultation. It covers consultation, ultrasound, tilt-table testing, transcranial Doppler, and EEG. Santa Fe: 2609075036B00057. Pachuca: 2613015036A00251.
Physician license (cédula) 09619992 (UAEMex). Neurology specialty license 14013199 (UNAM). Verifiable in Mexico’s National Register of Professionals.
Daniel Rebolledo García, M.D., neurologist. Clinical director of the Center.
Specialized outpatient diagnostic medical center. We provide comprehensive clinical evaluation, timely detection, and care for neurological conditions and disorders of the autonomic nervous system (dysautonomias), in a safe setting and with the highest professional standard for personalized patient care.
01
Tilt-table studies, cardiovascular responses, and non-invasive monitoring protocols adapted to real clinical practice.
02
Pure autonomic failure, nOH, and the transition toward parkinsonism or MSA in Mexican cohorts.
03
Clinical research that is relevant to the region, held to the same standard as referral centers elsewhere.
In Science We Trust
